In all, our findings suggest that NUCB2/Nesfatin-1 regulates cholesterol synthesis by improving SREBP2 and HMGCR abundance via the mTORC1 pathway, resulting in high metastasis ability in breast cancer both in vitro and in vivo. Here, HMGCR is linked to breast cancer.